Immunomodulatory compounds (IMiDs) in the treatment of multiple myeloma.

  title={Immunomodulatory compounds (IMiDs) in the treatment of multiple myeloma.},
  author={Gordan Srkalovi{\'c} and Mohamad Hussein},
  journal={Bosnian journal of basic medical sciences},
  volume={9 Suppl 1},
The design of innovative, more effective, less toxic therapy of multiple myeloma (MM) is emerging in parallel to a better understanding of the underlying pathophysiology of this common hematologic malignancy. Thalidomide has changed the treatment paradigm of patients with MM. Its efficacy, however, has been compromised by significant side effects. IMiDs… CONTINUE READING